Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection

Hepatology

Volumn 58, Issue 5, 2013, Pages 1569-1579

  Bukong, Terence N ^a   Kodys, Karen ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; EZRIN; F ACTIN; MOESIN; PROTEIN KINASE SYK; RADIXIN; RECOMBINANT ALPHA INTERFERON; TELAPREVIR;

ARTICLE; CELL DISRUPTION; FLUORESCENCE MICROSCOPY; GENE CONTROL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INFECTION SENSITIVITY; LIVER BIOPSY; MICROTUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPLICON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ENTRY; VIRUS REPLICATION; WESTERN BLOTTING;

CELL LINE; CYTOSKELETAL PROTEINS; HEPACIVIRUS; HEPATITIS C; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MICROTUBULES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; VIRUS REPLICATION;

EID: 84887022985     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26500     Document Type: Article

References (48)

1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-567.
2. Russell M, Pauly MP, Moore CD, Chia C, Dorrell J, Cunanan RJ, et al. The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan. Hepatology 2012;56:1223-1230.
3. Cawood J. Managing viral hepatitis C: HCV: new opportunities, high costtwo new biologics establish a higher standard of care. Managing these agents, however, will be highly complex. Biotechnol Healthc 2011;8:26-28.
4. Pawlotsky JM. Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus. Hepatology 2011;53:1742-1751.
5. Szabo G, Aloman C, Polyak SJ, Weinman SA, Wands J, Zakhari S. Hepatitis C infection and alcohol use: A dangerous mix for the liver and antiviral immunity. Alcohol Clin Exp Res 2006;30:709-719.
6. Francois C, Descamps V, Brochot E, Bernard I, Canva V, Mathurin P, et al. Relationship between the hepatitis C viral load and the serum interferon concentration during the first week of peginterferon-alpha-2b-ribavirin combination therapy. J Med Virol 2010;82:1640-1646.
7. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 2006;3:47-52.
8. Haedicke J, de Los Santos K, Goff SP, Naghavi MH. The ezrin-radixin-moesin family member ezrin regulates stable microtubule formation and retroviral infection. J Virol 2008;82:4665-4670.
9. Naghavi MH, Valente S, Hatziioannou T, de Los Santos K, Wen Y, Mott C, et al. Moesin regulates stable microtubule formation and limits retroviral infection in cultured cells. EMBO J 2007;26:41-52.
10. Lai CK, Jeng KS, Machida K, Lai MM. Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A. J Virol 2008;82:8838-8848.
11. Huthoff H, Towers GJ. Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha. Trends Microbiol 2008;16:612-619.
12. Malamud D, Abrams WR, Barber CA, Weissman D, Rehtanz M, Golub E. Antiviral activities in human saliva. Adv Dent Res 2011;23:34-37.
13. Salamov G, Holms R, Bessler WG, Ataullakhanov R. Treatment of hepatitis C virus infection with human ezrin peptide one (HEP1) in HIV infected patients. Arzneimittelforschung 2007;57:497-504.
14. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
15. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 1993;67:1385-1395.
16. Bradley DW, McCaustland KA, Cook EH, Schable CA, Ebert JW, Maynard JE. Posttransfusion non-A, non-B hepatitis in chimpanzees. Physicochemical evidence that the tubule-forming agent is a small, enveloped virus. Gastroenterology 1985;88:773-779.
17. Gudat F, Eder G, Eder C, Bianchi L, Stocklin E, Krey G, et al. Experimental non-A, non-B hepatitis in chimpanzees: light, electron and immune microscopical observations. Liver 1983;3:110-121.
18. Pfeifer U, Thomssen R, Legler K, Bottcher U, Gerlich W, Weinmann E, et al. Experimental non-A, non-B hepatitis: four types of cytoplasmic alteration in hepatocytes of infected chimpanzees. Virchows Arch B 1980;33:233-243.
19. Schaff Z, Eder G, Eder C, Lapis K. Intracytoplasmic crystalline inclusions in the hepatocytes of humans and chimpanzees. Ultrastruct Pathol 1990;14:303-309.
20. Spichtin HP, Gudat F, Schmid M, Pirovino M, Altorfer J, Bianchi L. Microtubular aggregates in human chronic non-A, non-B hepatitis with bridging hepatic necrosis and multinucleated hepatocytic giant cells. Liver 1982;2:355-360.
21. Yoshizawa H, Itoh Y, Iwakiri S, Kitajima K, Noguchi Y, Tachibana K, et al. Beta-propiolactone for the inactivation of non-A/non-B type 1 hepatitis virus capable of inducing cytoplasmic tubular ultrastructures in chimpanzees. Vox Sang 1984;46:86-91.
22. Revie D, Salahuddin SZ. Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence. Virol J 2011;8:346.
23. Meredith LW, Wilson GK, Fletcher NF, McKeating JA. Hepatitis C virus entry: beyond receptors. Rev Med Virol 2012;22:182-193.
24. Diao J, Pantua H, Ngu H, Komuves L, Diehl L, Schaefer G, et al. Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry. J Virol 2012;86:10935-10949.
25. Coffey GP, Rajapaksa R, Liu R, Sharpe O, Kuo CC, Krauss SW, et al. Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin. J Cell Sci 2009;122:3137-3144.
26. Bost AG, Venable D, Liu L, Heinz BA. Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system. J Virol 2003;77:4401-4408.
27. Ivetic A, Ridley AJ. Ezrin/radixin/moesin proteins and Rho GTPase signalling in leucocytes. Immunology 2004;112:165-176.
28. Neisch AL, Fehon RG. Ezrin, radixin and moesin: key regulators of membrane-cortex interactions and signaling. Curr Opin Cell Biol 2011;23:377-382.
29. Andreoli C, Martin M, Le Borgne R, Reggio H, Mangeat P. Ezrin has properties to self-associate at the plasma membrane. J Cell Sci 1994;107(Pt 9):2509-2521.
30. Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 2002;76:13001-13014.
31. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, et al. Complete replication of hepatitis C virus in cell culture. Science 2005;309:623-626.
32. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al. Binding of hepatitis C virus to CD81. Science 1998;282:938-941.
33. Crotta S, Ronconi V, Ulivieri C, Baldari CT, Valiante NM, Abrignani S, et al. Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells. Eur J Immunol 2006;36:919-929.
34. Wack A, Soldaini E, Tseng C, Nuti S, Klimpel G, Abrignani S. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur J Immunol 2001;31:166-175.
35. Tsuchida S, Yanagi S, Inatome R, Ding J, Hermann P, Tsujimura T, et al. Purification of a 72-kDa protein-tyrosine kinase from rat liver and its identification as Syk: involvement of Syk in signaling events of hepatocytes. J Biochem 2000;127:321-327.
36. Inubushi S, Nagano-Fujii M, Kitayama K, Tanaka M, An C, Yokozaki H, et al. Hepatitis C virus NS5A protein interacts with and negatively regulates the non-receptor protein tyrosine kinase Syk. J Gen Virol 2008;89:1231-1242.
37. Rice CM. New insights into HCV replication: potential antiviral targets. Top Antivir Med 2011;19:117-120.
38. Roberts KL, Baines JD. Actin in herpesvirus infection. Viruses 2011;3:336-346.
39. Barrero-Villar M, Cabrero JR, Gordon-Alonso M, Barroso-Gonzalez J, Alvarez-Losada S, Munoz-Fernandez MA, et al. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes. J Cell Sci 2009;122:103-113.
40. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000;290:1972-1974.
41. Manneville JB, Etienne-Manneville S, Skehel P, Carter T, Ogden D, Ferenczi M. Interaction of the actin cytoskeleton with microtubules regulates secretory organelle movement near the plasma membrane in human endothelial cells. J cell Sci 2003;116:3927-3938.
42. Sala-Valdes M, Ursa A, Charrin S, Rubinstein E, Hemler ME, Sanchez-Madrid F, et al. EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with ezrin-radixin-moesin proteins. J Biol Chem 2006;281:19665-19675.
43. Montpellier C, Tews BA, Poitrimole J, Rocha-Perugini V, D'Arienzo V, Potel J, et al. Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection. J Biol Chem 2011;286:13954-13965.
44. Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K, et al. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell biol 1998;140:647-657.
45. Bukong TN, Hou W, Kodys K, Szabo G. Ethanol facilitates HCV replication via upregulation of GW182 and HSP90 in human hepatoma cells. Hepatology 2013;57:70-80.
46. Hao JJ, Liu Y, Kruhlak M, Debell KE, Rellahan BL, Shaw S. Phospholipase C-mediated hydrolysis of PIP2 releases ERM proteins from lymphocyte membrane. J Cell Biol 2009;184:451-462.
47. He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995;69:6705-6711.
48. Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995;206:935-944.